Connect Biopharma (CNTB) Institutional Ownership → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CNTB Stock Alerts $1.40 +0.03 (+2.19%) (As of 12:11 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Connect Biopharma (NASDAQ:CNTB)CurrentInstitutional OwnershipPercentage58.72%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.43MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$231.25K Get CNTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Connect Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CNTB Institutional Buying and Selling by Quarter Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Connect Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/30/2024 BML Capital Management LLC2,061,438$2.43M1.8%N/A3.743% 8/15/2023Kynam Capital Management LP535,005$603K0.1%-27.7%0.972% 11/14/2022Boothbay Fund Management LLC26,867$35K0.0%-65.5%0.049% 8/16/2022DAFNA Capital Management LLC250,000$218K0.1%N/A0.454% 5/13/2022Kynam Capital Management LP227,759$688K0.2%N/A0.414% 2/22/2022DLD Asset Management LP121,707$627K0.0%N/A0.212% Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/2022DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022Adage Capital Partners GP L.L.C.1,250,000$6.44M0.0%N/A2.174% 2/14/2022Altium Capital Management LP175,000$901K0.2%N/A0.304% 2/14/2022Deep Track Capital LP647,057$3.33M0.2%N/A1.125% 2/11/2022Ensign Peak Advisors Inc25,412$131K0.0%N/A0.044% 11/16/2021Janus Henderson Group PLC403,459$9.57M0.0%+3.1%0.702% 11/16/2021Wellington Management Group LLP1,145,177$27.37M0.0%-25.3%1.991% 11/12/2021Vident Investment Advisory LLC10,851$263K0.0%N/A0.019% 11/9/2021BlackRock Inc.2,450,065$59.37M0.0%-0.3%4.261% 11/5/2021Daiwa Securities Group Inc.6,069$147K0.0%N/A0.011% 8/17/2021Millennium Management LLC42,856$837K0.0%+286.1%0.075% 8/17/2021Old Well Partners LLC122,431$2.39M1.1%N/A0.213% 8/16/2021RA Capital Management L.P.6,991,003$136.53M2.2%+133.7%12.157% 8/16/2021Federated Hermes Inc.12,000$234K0.0%-70.0%0.021% 8/13/2021FMR LLC3,925,836$76.67M0.0%+23.3%6.827% 8/11/2021BlackRock Inc.2,458,132$48.01M0.0%+0.3%4.275% 8/10/2021Citigroup Inc.1,413$28K0.0%N/A0.002% 5/19/2021Logos Global Management LP150,000$2.78M0.3%N/A0.261% 5/19/2021Octagon Capital Advisors LP373,492$6.91M2.6%N/A0.650% 5/18/2021Millennium Management LLC11,099$205K0.0%N/A0.019% 5/18/2021Zimmer Partners LP10,000$185K0.0%N/A0.017% 5/18/2021RA Capital Management L.P.2,991,208$55.34M0.8%N/A5.202% 5/18/2021State of Wisconsin Investment Board100,272$1.86M0.0%N/A0.174% 5/18/2021Alyeska Investment Group L.P.50,000$925K0.0%N/A0.087% 5/18/2021Boxer Capital LLC2,081,323$38.50M1.3%N/A3.619% 5/18/2021Cormorant Asset Management LP1,000,000$18.50M0.4%N/A1.739% 5/18/2021Citadel Advisors LLC245,191$4.54M0.0%N/A0.426% 5/17/2021Point72 Hong Kong Ltd10,426$193K0.0%N/A0.018% 5/17/2021Rock Springs Capital Management LP119,114$2.20M0.0%N/A0.207% 5/17/2021DAFNA Capital Management LLC8,000$148K0.0%N/A0.014% 5/17/2021Janus Henderson Group PLC475,000$8.70M0.0%N/A0.826% 5/17/2021Pinz Capital Management LP43,100$797K0.2%N/A0.075% 5/17/2021Sphera Funds Management LTD.50,000$925K0.1%N/A0.087% 5/14/2021RTW Investments LP450,000$8.33M0.1%N/A0.783% This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry5/14/2021Monashee Investment Management LLC110,000$2.04M0.3%N/A0.191% 5/13/2021Federated Hermes Inc.40,000$740K0.0%N/A0.070% (Data available from 1/1/2016 forward) CNTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNTB shares? During the previous two years, the following institutional investors and hedge funds held shares of Connect Biopharma shares: BML Capital Management LLC ($2.43M), Kynam Capital Management LP ($603K), and DAFNA Capital Management LLC ($218K), Boothbay Fund Management LLC ($35K).Learn more on CNTB's institutional investors. What percentage of Connect Biopharma stock is owned by institutional investors? 58.72% of Connect Biopharma stock is owned by institutional investors. Learn more on CNTB's institutional investor holdings. Which institutional investors have been buying Connect Biopharma stock? The following institutional investors have purchased Connect Biopharma stock in the last 24 months: BML Capital Management LLC ($2.06M), DAFNA Capital Management LLC ($250K), and Kynam Capital Management LP ($227.76K). How much institutional buying is happening at Connect Biopharma? Institutional investors have bought a total of 2,539,197 shares in the last 24 months. This purchase volume represents approximately $3.34M in transactions. Which Connect Biopharma major shareholders have been selling company stock? The following institutional investors have sold Connect Biopharma stock in the last 24 months: Kynam Capital Management LP ($204.64K), and Boothbay Fund Management LLC ($50.98K). How much institutional selling is happening at Connect Biopharma? Institutional investors have sold a total of 255,628 shares in the last 24 months. This volume of shares sold represents approximately $297.02K in transactions. Related Companies: TPST Institutional Ownership SPRO Institutional Ownership HOOK Institutional Ownership YS Institutional Ownership CRVS Institutional Ownership MRNS Institutional Ownership VTVT Institutional Ownership ONCY Institutional Ownership IFRX Institutional Ownership CUE Institutional Ownership This page (NASDAQ:CNTB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmith“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
